Showing results (71-80 of 122) with videos related to
Sort By:
Pageof 13
Breast Cancer (Tokyo, Japan)|February 16, 2021
Impact of tumor cellularity on the HER2 amplification assay by OncoScan™ in breast cancerAko Ohara, Yasuto Naoi, Masafumi Shimoda, et al.European Journal of Cancer (Oxford, England : 1990)|July 12, 2011
Association between c-myc amplification and pathological complete response to neoadjuvant chemotherapy in breast cancerHiroyuki Yasojima, Atsushi Shimomura, Yasuto Naoi, et al.Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS|April 25, 2021
Aesthetic utility of addition of nipple-areola recentralization to rotation flap according to nipple tumor distance for patients with lower-outer or upper-inner located breast cancersTomohiro Miyake, Naofumi Kagara, Masafumi Shimoda, et al.Breast Cancer Research and Treatment|September 19, 2012
Intratumoral regulatory T cells as an independent predictive factor for pathological complete response to neoadjuvant paclitaxel followed by 5-FU/epirubicin/cyclophosphamide in breast cancer patientsNaofumi Oda, Kenzo Shimazu, Yasuto Naoi, et al.Annals of Surgical Oncology|June 26, 2020
Development of Prediction Model Including MicroRNA Expression for Sentinel Lymph Node Metastasis in ER-Positive and HER2-Negative Breast CancerJun Okuno, Tomohiro Miyake, Yoshiaki Sota, et al.Cancers|May 13, 2023
Detection of Ultra-Rare <i>ESR1</i> Mutations in Primary Breast Cancer Using LNA-Clamp ddPCRYoko Hashimoto, Nanae Masunaga, Naofumi Kagara, et al.Cancers|July 12, 2025
High HER2 Intratumoral Heterogeneity Is Resistant to Anti-HER2 Neoadjuvant Chemotherapy in Early Stage and Locally Advanced HER2-Positive Breast CancerTakaaki Hatano, Tomonori Tanei, Shigeto Seno, et al.Biomolecules|September 28, 2024
Expression of Periostin Alternative Splicing Variants in Normal Tissue and Breast CancerYuko Kanemoto, Fumihiro Sanada, Kana Shibata, et al.Cells|September 14, 2024
The Importance of Suppressing Pathological Periostin Splicing Variants with Exon 17 in Both Stroma and CancerKana Shibata, Nobutaka Koibuchi, Fumihiro Sanada, et al.Breast Cancer Research and Treatment|July 26, 2013
Comparison of efficacy of 95-gene and 21-gene classifier (Oncotype DX) for prediction of recurrence in ER-positive and node-negative breast cancer patientsYasuto Naoi, Kazuki Kishi, Ryo Tsunashima, et al.Pageof 13